Literature DB >> 8094377

Generation and purification of recombinant fimbrillin from Porphyromonas (Bacteroides) gingivalis 381.

O R Washington1, M Deslauriers, D P Stevens, L K Lyford, S Haque, Y Yan, P M Flood.   

Abstract

Fimbrillin is the major subunit protein of fimbriae from the human periodontal pathogen Porphyromonas (Bacteroides) gingivalis. We describe here the generation and initial characterization of recombinant fimbrillin (r-fimbrillin) isolated from P. gingivalis 381. A fragment of DNA encoding the gene for fimbrillin was generated by polymerase chain reaction and cloned into the expression vector pET11b. Plasmids containing the recombinant gene were transfected into Escherichia coli. Clones were selected on plates for ampicillin resistance and individually screened by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for protein production after activation with IPTG (isopropyl-beta-D- thiogalactopyranoside). One clone, OW0.2, produced significant amounts of a 42-kDa protein after induction with IPTG. This clone contained the pET11b plasmid with a 1-kb insert that had sequence homology to the gene encoding fimbrillin. The majority of recombinant protein from clone OW0.2 was found in the cytoplasm within inclusion bodies. Protein aggregates were solubilized in 8 M urea, and SDS-PAGE analysis showed two major protein bands, one at 42 kDa and the other at 17 kDa. These two proteins coeluted from a DEAE-Sepharose column at 0.15 M NaCl and were reactive to rabbit antiserum to fimbrillin in a Western blot (immunoblot). A preparation giving a single protein band at 42 kDa in SDS-PAGE was obtained by size fractionation by using continuous-elution electrophoresis. Lymph node cells from animals immunized with either fimbrillin from P. gingivalis or r-fimbrillin showed antigen-specific proliferation to both P. gingivalis fimbrillin and r-fimbrillin in an in vitro recall assay. Therefore, it appears that r-fimbrillin is chemically, antigenically, and serologically identical to fimbrillin isolated from P. gingivalis 381.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094377      PMCID: PMC302836          DOI: 10.1128/iai.61.3.1040-1047.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Epitope mapping of hemagglutinating adhesion HA-Ag2 of Bacteroides (Porphyromonas) gingivalis.

Authors:  M Deslauriers; C Mouton
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Immunobiological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis.

Authors:  T Ogawa; Y Kusumoto; H Uchida; S Nagashima; H Ogo; S Hamada
Journal:  Biochem Biophys Res Commun       Date:  1991-11-14       Impact factor: 3.575

3.  Fast and sensitive detection of protein and DNA bands by treatment with potassium permanganate.

Authors:  W Ansorge
Journal:  J Biochem Biophys Methods       Date:  1985-05

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.

Authors:  E C Tramont; J C Sadoff; J W Boslego; J Ciak; D McChesney; C C Brinton; S Wood; E Takafuji
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

7.  Do pili play a role in pathogenicity of Haemophilus influenzae type B?

Authors:  M E Pichichero; M Loeb; D H Smith
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

8.  Colonization of the subgingival area by Bacteroides gingivalis.

Authors:  I Takazoe; T Nakamura; K Okuda
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

9.  Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis.

Authors:  F Yoshimura; K Takahashi; Y Nodasaka; T Suzuki
Journal:  J Bacteriol       Date:  1984-12       Impact factor: 3.490

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  6 in total

1.  Binding sites of salivary statherin for Porphyromonas gingivalis recombinant fimbrillin.

Authors:  A Amano; K Kataoka; P A Raj; R J Genco; S Shizukuishi
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Characterization of recombinant and native forms of a cell surface antigen of Porphyromonas (Bacteroides) gingivalis.

Authors:  A Joe; A Yamamoto; B C McBride
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics.

Authors:  A Sharma; H T Sojar; J Y Lee; R J Genco
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

4.  Identification of murine protective epitopes on the Porphyromonas gingivalis fimbrillin molecule.

Authors:  M Deslauriers; S Haque; P M Flood
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

5.  Proteins with molecular masses of 50 and 80 kilodaltons encoded by genes downstream from the fimbrilin gene (fimA) are components associated with fimbriae in the oral anaerobe Porphyromonas gingivalis.

Authors:  F Yoshimura; Y Takahashi; E Hibi; T Takasawa; H Kato; D P Dickinson
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Structural domains of Porphyromonas gingivalis recombinant fimbrillin that mediate binding to salivary proline-rich protein and statherin.

Authors:  A Amano; A Sharma; J Y Lee; H T Sojar; P A Raj; R J Genco
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.